The VTE PSP is an initiative of the Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) network in partnership with the James Lind Alliance.
The goal of the VTE PSP is to engage with patients, caregivers and clinicians to identify uncertainties about the prevention, diagnosis, management and long term impact of VTE and its associated treatments on patients, caregivers, and their families. These uncertainties will be used to guide future research.